MBX BiosciencesMBX

13F holders, Q3 2024 (September 30)
45holders
4famous investors
$25.87avg. 13F price*

At the end of Q3 2024, 45 institutions reported holding MBX Biosciences Inc. (MBX) in their 13F filings. The largest holders were Frazier Life Sciences Management, L.P. ($155.5M), Orbimed Advisors LLC ($99.0M) and NEA Management Company, LLC ($93.9M). 4 famous investors held it, including George Soros (0.0% of Soros Fund Management's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
MBX Biosciences Inc.
CUSIP
55287L101
Latest filing quarter
Q2 2026

History

Number of 13F holders

050100150200 Q3 2024: 45Q3 2024Q4 2024: 63Q4 2024Q1 2025: 79Q1 2025Q2 2025: 88Q2 2025Q3 2025: 118Q3 2025Q4 2025: 138Q4 2025Q1 2026: 157Q1 2026Q2 2026: 172Q2 2026

Total Exit/New Position Q3 2024

InstitutionsTotal Value
New Positions45$784.0M
Exits0$0

Ownership 45 holders

Frazier Life Sciences Management, L.P. 6.24% New 5,985,347 $155.5M
Orbimed Advisors LLC 1.81% New 3,812,215 $99.0M
NEA Management Company, LLC 5.12% New 3,614,486 $93.9M
Deep Track Capital, LP 2.50% New 3,018,935 $78.4M
Wellington Management Group LLP 0.01% New 2,937,853 $74.3M
NVP Associates, LLC 31.51% New 2,136,335 $55.5M
Ra Capital Management, L.P. 0.45% New 1,511,334 $39.3M
T. Rowe Price Associates Inc. 0.00% New 1,192,938 $31.0M
EcoR1 Capital, LLC 1.05% New 1,175,809 $30.5M
Driehaus Capital Management LLC 0.22% New 981,322 $25.5M
Cormorant Asset Management, LP 0.96% New 700,000 $18.2M
TCG Crossover Management, LLC 1.43% New 650,000 $16.9M
Woodline Partners LP 0.11% New 519,675 $13.5M
Millennium Management 0.01% New 440,411 $11.4M
Franklin Resources Inc. 0.00% New 450,000 $10.6M
Alyeska Investment Group, L.P. 0.03% New 225,000 $5.8M
Platinum Investment Management Ltd. 0.18% New 150,000 $3.9M
Citadel Advisors 0.00% New 135,608 $3.5M
Goldman Sachs Group Inc. 0.00% New 51,000 $1.3M
Stempoint Capital LP 0.39% New 50,000 $1.3M
Maven Securities LTD 0.15% New 50,000 $1.3M
Monashee Investment Management LLC 0.14% New 50,000 $1.3M
Vanguard Group Inc. 0.00% New 50,000 $1.3M
Manufacturers Life Insurance Company, The 0.00% New 46,194 $1.2M
TD Asset Management Inc 0.00% New 44,782 $1.1M
Ghisallo Capital Management LLC 0.04% New 30,000 $779K
Soros Fund Management 0.02% New 30,000 $779K
Teachers Retirement System of the State of Kentucky 0.01% New 26,708 $694K
Jane Street Group, LLC 0.00% New 26,570 $690K
Norges Bank 0.00% New 25,000 $650K
Point72 (DIFC) Ltd 0.05% New 24,011 $624K
Geode Capital Management, LLC 0.00% New 22,269 $579K
HRT Financial LP 0.00% New 21,637 $562K
Squarepoint Ops LLC 0.00% New 16,470 $428K
Barclays PLC 0.00% New 16,400 $426K
Point72 Asset Management 0.00% New 15,600 $405K
Shay Capital LLC 0.12% New 15,000 $390K
Davidson Kempner Capital Management LP 0.01% New 13,500 $338K
Marshall Wace, LLP 0.00% New 12,000 $312K
Point72 Asia (Singapore) Pte. Ltd. 0.05% New 10,706 $278K
Capula Management Ltd 0.00% New 8,362 $217K
Sandia Investment Management LP 0.21% New 5,000 $130K
Legal & General Group Plc 0.00% New 5,000 $128K
Aster Capital Management (DIFC) Ltd 0.01% — 1,810 $47K
Tower Research Capital LLC (TRC) 0.00% New 154 $4K

"% of holder's portfolio" is MBX's weight in each manager's 13F, not the share of MBX Biosciences Inc. the manager owns.